Use of nuclear myocardial perfusion imaging exams dropped sharply between 2006 and 2011, but substitute imaging studies haven’t increased.
Use of nuclear myocardial perfusion imaging (MPI) has decreased significantly, according to a recent study in JAMA.
Researchers from Kaiser Permanente Medical Center in San Francisco, Calif., examined trends of MPI use from 2000 to 2011. The researchers obtained data regarding patients, aged 30 years or older, who underwent MPI within the healthcare delivery system.
The findings showed that MPI was used for 302,506 patients at 19 facilities. The imaging use increased by a relative 41 percent from 2000 to 2006. However, from 2006 to 2011, MPI use dropped by a relative 51 percent. Use dropped by 58 percent among outpatients and 31 percent among inpatients and for patients under age 65.
When looking to see if other imaging tests increased as a result of the MPI decrease, the researchers found that use of cardiac CT did increase and could have accounted for 5 percent of the observed decline in overall MPI use if performed as a substitute.
“The substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in health care costs,” wrote authors Edward J. McNulty, MD, and colleagues.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.